[1]曹岚,侯瑞田,王福慧,等.Lp-PLA2血小板相关因子与2型糖尿病合并高血压病的 相关性研究[J].医学信息,2018,31(05):3-6,10.[doi:10.3969/j.issn.1006-1959.2018.05.002]
 CAO Lan,HOU Rui-tian,WANG Fu-hui,et al.Study on the Correlation between Lp-PLA2 Platelet-associated Factors and Type 2 Diabetes Mellitus Complicated with Hypertension[J].Journal of Medical Information,2018,31(05):3-6,10.[doi:10.3969/j.issn.1006-1959.2018.05.002]
点击复制

Lp-PLA2血小板相关因子与2型糖尿病合并高血压病的 相关性研究()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年05期
页码:
3-6,10
栏目:
出版日期:
2018-03-01

文章信息/Info

Title:
Study on the Correlation between Lp-PLA2 Platelet-associated Factors and Type 2 Diabetes Mellitus Complicated with Hypertension
文章编号:
1006-1959(2018)05-0003-05
作者:
曹岚1侯瑞田2王福慧1葛晓春2何建秋2甄江伟1金凤表2
1.承德医学院,河北 承德 067000;2.承德医学院附属医院内分泌科,河北 承德 067000
Author(s):
CAO Lan1HOU Rui-tian2WANG Fu-hui1GE Xiao-chun2HE Jian-qiu2ZHEN Jiang-wei1 JIN Feng-biao2
1.Chengde Medical College,Chengde 067000,Hebei,China; 2.Department of Endocrinology,Affiliated Hospital of Chengde Medical College,Chengde 067000,Hebei,China
关键词:
2型糖尿病高血压病Lp-PLA2血小板相关因子
Keywords:
Key words:Type 2 diabetes mellitusHypertensionLp-PLA2Platelet-associated factors
分类号:
R587.1;R544.1
DOI:
10.3969/j.issn.1006-1959.2018.05.002
文献标志码:
A
摘要:
目的 探讨脂蛋白相关性磷脂酶A2(Lp-PLA2)、血小板相关因子与2型糖尿病合并高血压病患者的相关性。方法 连续入选我院2型糖尿病患者共102例,分为2型糖尿病合并高血压病组(n=50)、单纯2型糖尿病组(n=52),以及同期住院的单纯高血压病组(n=30)、体检健康对照组(n=30)。记录四组患者一般资料、生化指标及血小板相关因子--血小板计数(PLT)、血小板分布宽度(PDW)、平均血小板容积(MPV)及大血小板比率(P-LCR)水平,并测定Lp-PLA2水平。结果 四组间性别、年龄、ALT、AST、Scr、BUN、TCH比较,差异无统计学意义(P>0.05)。2型糖尿病合并高血压病患者的Lp-PLA2及PDW、MPV、P-LCR水平较单纯2型糖尿病患者、单纯高血压病组及健康对照组升高,差异有统计学意义(P<0.05);PLT较单纯2型糖尿病组、单纯高血压病组及健康对照组降低,差异有统计学意义(P<0.05)。Lp-PLA2、PDW与收缩压(SBP)成正相关(P<0.05),Lp-PLA2、PDW、MPW、P-LCT与糖化血红蛋白(HbA1c)成正相关(P<0.05)。结论 Lp-PLA2、血小板相关因子可评估2型糖尿病患者血管内皮功能状态,合并高血压病的2型糖尿病患者血管内皮功能障碍更加严重,且该严重程度与血压、血糖控制不佳的程度有关。
Abstract:
Abstract:Objective To investigate the relationship between lipoprotein associated phospholipase A2(Lp-PLA2),platelet related factors and type 2 diabetes mellitus complicated with hypertension.Methods 102 patients with type 2 diabetes mellitus were enrolled in our hospital.The patients were divided into two groups:type 2 diabetes mellitus complicated with hypertension group(n=50),type 2 diabetes group(n=52),hypertension group(n=30)and healthy control group(n=30).The general data, biochemical parameters and platelet related factor-platelet count(PLT),platelet distribution width(PDW),mean platelet volume(MPV)and large platelet ratio(P-LCR)were recorded in the four groups,and the level of Lp-PLA2 was measured.Results There was no significant difference in the age,sex,ALT,AST,Scr,BUN,TCH among the four groups(P>0.05).Type 2 diabetes mellitus and hypertension in patients with Lp-PLA2 and PDW, MPV and P-LCR levels higher than patients with type 2 diabetes mellitus,hypertension group and healthy control group increased,the difference was statistically significant(P<0.05);PLT compared with type 2 diabetes group and simple hypertension group and healthy control group decreased,with statistical significance the difference(P<0.05).Lp-PLA2 and PDW were positively correlated with systolic blood pressure(SBP)(P<0.05),and Lp-PLA2,PDW,MPW and P-LCT were positively correlated with glycosylated hemoglobin(HbA1c) (P<0.05).Conclusion Lp-PLA2 and platelet related factors can evaluate endothelial function in patients with type 2 diabetes mellitus, and endothelial dysfunction is more severe in type 2 diabetic patients with hypertension,and the severity is related to the degree of blood pressure and blood sugar control.

参考文献/References:

[1]中国糖尿病防控专家共识专家组.中国糖尿病防控专家共识[J].中华预防医学杂志,2017,51(1):12. [2]中国高血压防治指南修订委员会.中国高血压防治指南2010[J].中国医学前沿杂志,2011,3(5):42-93. [3]Eapen DJ,Manocha P,Patel RS,et al.Aggregate Risk Score Based on Markers of Inflammation,Cell Stress,and Coagulation is an Independent Predictor of Adverse Cardiovascular Outcomes[J].J Am Coll Cardiol,2013,62(4):329-337. [4]中华医学会糖尿病分会.中国2型糖尿病防治指南(2013年版)[J].中华糖尿病杂志,2014,6(7):447-498. [5]Anna C Roberts,Karen E Porter.Cellular and molecular mechanisms of endothelial dysfunction in diabetes[J].Diab Vasc Dis Res,2013,10(6):472-482. [6]Krzych LJ,Bochenek A.Blood pressure variability:Epidemiological and issues[J].Cardiol J,2013,20(2):112-120. [7]Altiparmak IH,Erkus ME,Gunebakmaz O.Oxidative stress is associated with not only coronary artery disease on statin therapy but also diabetes mellitus and hypertension[J].Indian Heart J,2016,68(2):194-195. [8]Tibaut M,Petrovic D.Oxidative stress genes,antioxidants and coronary artery disease in type 2 diabetes mellitus[J].Cardiovasc Hematol Agents Med Chem,2016,14(1):23-38. [9]Rask-Madsen C,King GL.Mechanisms of disease:endothelial dysfunction in insulin resistance and diabetes[J].Nat Clin Pract Endocrinol Metab,2015,11(2):46-56. [10]Zaccardi F,Rocca B,Pitocco D,et al.Platelet mean volume,distribution width,and count in type 2 diabetes,impaired fasting glucose,and metabolic syndrome:A meta-analysis[J].Diabetes Metab Res Rev,2015,31(4):402-410.[11]Giuseppe Maiolino,Valeria Bisogni,Giacomo Rossitto,et al.Lipoprotein-associated phospholipase A2 prognostic role in atherosclerotic complications[J].World J Cardiol,2015,7(10):609-620. [12]He S,Chousterman BG,Fenn A,et al.Lp-PLA2 antagonizes left ventricular healing after myocardial infarction by impairing the appearance of reparative macrophages[J].Circ Heart Fail,2015,8(5):980-987. [13]Tellis CC,Tselepis AD.Pathophysiological Role and Clinical Significance of Lipoprotein-Associated Phospholipase A2(Lp-PLA2)Bound to LDL and HDL[J].Curr Pharm Des,2014(40):6256-6269. [14]Kim M,Jeung SR,Jeong TS,et al.Replacing with whole grains and legumes reduces lipoprotein-associated phospholipase A2(Lp-PLA2)activities in plasma and peripheral blood mononuclear cells in patients with prediabetes or newly diagnosed type 2 diabetes[J].J Lipid Res,2014,55(4):1762-1771. [15]Archana Buch,Supreet Kaur,Ambuj Jain,et al.Platelet volume indices as predictive biomarkers for diabetic complications in Type 2 diabetic patients[J].J Lab Physicians,2017,9(2):84-88. [16]Cheraghi A,Mahmoudi M,Jafarian K,et al.Comparison of Serum LP-PLA2 Level and some Nutritional Factors between Well-Controlled and Poorly-Controlled Diabetic Patients[J].Acta Med Iran,2015,53(11):690-696.

相似文献/References:

[1]黄德斌,章臻翊,章 婷,等.2型糖尿病患者亚临床甲状腺功能减退与白蛋白尿的关系研究[J].医学信息,2018,31(02):88.[doi:10.3969/j.issn.1006-1959.2018.02.030]
 HUANG De-bin,ZHANG Zhen-yi,ZHANG Ting,et al.Relationship between Subclinical Hypothyroidism and Albuminuria in Patients with Type 2 Diabetes Mellitus[J].Journal of Medical Information,2018,31(05):88.[doi:10.3969/j.issn.1006-1959.2018.02.030]
[2]邓婷婷,王亚洲,张 红.口福怡稻治疗2型糖尿病的临床效果研究[J].医学信息,2018,31(03):116.[doi:10.3969/j.issn.1006-1959.2018.03.039]
 DENG Ting-ting,WANG Ya-zhou,ZHANG Hong.Clinical Study on the Treatment of Type 2 Diabetes Mellitus with Kou Fuyi Dao[J].Journal of Medical Information,2018,31(05):116.[doi:10.3969/j.issn.1006-1959.2018.03.039]
[3]靳雪芹,邓正聪.代谢综合征与肿瘤关系的研究进展[J].医学信息,2018,31(05):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
 JIN Xue-qin,DENG Zheng-cong.Research Progress on the Relationship between Metabolic Syndrome and Tumor[J].Journal of Medical Information,2018,31(05):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
[4]刘 洪.地特胰岛素或甘精胰岛素联合使用口服药物治疗2型糖尿病疗效及对体重的影响分析[J].医学信息,2018,31(09):135.[doi:10.3969/j.issn.1006-1959.2018.09.042]
 LIU Hong.Effect of Insulin Detemir or Insulin Glargine Combined with Oral Medication on Type 2 Diabetes Mellitus and its Influence on Body Weight[J].Journal of Medical Information,2018,31(05):135.[doi:10.3969/j.issn.1006-1959.2018.09.042]
[5]郭云飞,王亚柱,刘 超,等.血浆致动脉硬化指数与冠心病合并2型糖尿病的相关性分析[J].医学信息,2022,35(09):108.[doi:10.3969/j.issn.1006-1959.2022.09.027]
 GUO Yun-fei,WANG Ya-zhu,LIU Chao,et al.Correlation Between Plasma Arteriosclerosis Index and Coronary Heart Disease Complicated with Type 2 Diabetes Mellitus[J].Journal of Medical Information,2022,35(05):108.[doi:10.3969/j.issn.1006-1959.2022.09.027]
[6]徐晨曦.达格列净联合DPP-4抑制剂与二甲双胍对血糖控制不佳2型糖尿病患者血糖及脂代谢的影响[J].医学信息,2022,35(09):165.[doi:10.3969/j.issn.1006-1959.2022.09.042]
 XU Chen-xi.Effects of Daglitazone Combined with DPP-4 Inhibitor and Metformin on Blood Glucose and Lipid Metabolism in Patients with Type 2 Diabetes Mellitus with Poor Glycemic Control[J].Journal of Medical Information,2022,35(05):165.[doi:10.3969/j.issn.1006-1959.2022.09.042]
[7]余 佳.早期胰岛素强化治疗对初诊2型糖尿病患者血糖控制效果及颈动脉粥样硬化进展的影响[J].医学信息,2022,35(10):140.[doi:10.3969/j.issn.1006-1959.2022.10.034]
 YU Jia.Effect of Early Intensive Insulin Therapy on Blood Glucose Control and Progression of Carotid Atherosclerosis in Newly Diagnosed Type 2 Diabetic Mellitus Patients[J].Journal of Medical Information,2022,35(05):140.[doi:10.3969/j.issn.1006-1959.2022.10.034]
[8]张剑君.2型糖尿病参与血管衰老的机制[J].医学信息,2022,35(11):37.[doi:10.3969/j.issn.1006-1959.2022.11.011]
 ZHANG Jian-jun.The Mechanism of Type 2 Diabetes Mellitus in Vascular Aging[J].Journal of Medical Information,2022,35(05):37.[doi:10.3969/j.issn.1006-1959.2022.11.011]
[9]刘静波,黄 萍,赵 静.应用微信平台对初发中青年2型糖尿病患者进行 健康管理模式的研究[J].医学信息,2018,31(14):98.[doi:10.3969/j.issn.1006-1959.2018.14.028]
 LIU Jing-bo,HUANG Ping,ZHAO Jing.Study on the Health Management Model of Young and Middle-aged Patients with Type 2 Diabetes Mellitus by WeChat Platform[J].Journal of Medical Information,2018,31(05):98.[doi:10.3969/j.issn.1006-1959.2018.14.028]
[10]丁 星,赵 畅,张海严,等.麦邦数据远程传输型血糖仪临床测量准确性的评价研究[J].医学信息,2018,31(15):64.[doi:10.3969/j.issn.1006-1959.2018.15.020]
 DING Xing,ZHAO Chang,ZHANG Hai-yan,et al.Evaluation of Accuracy of Clinical Measurement of Maibang Remote Data Transmission Glucometer[J].Journal of Medical Information,2018,31(05):64.[doi:10.3969/j.issn.1006-1959.2018.15.020]

更新日期/Last Update: 2018-03-01